HUTCHMED (LON:HCM) Shares Cross Below 200 Day Moving Average - Should You Sell?

HUTCHMED (China) Limited (LON:HCM - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 253.72 ($3.37) and traded as low as GBX 213 ($2.83). HUTCHMED shares last traded at GBX 225 ($2.99), with a volume of 97,113 shares trading hands.

HUTCHMED Trading Up 2.4 %

The firm has a 50-day moving average price of GBX 231.04 and a 200-day moving average price of GBX 252.01. The company has a current ratio of 2.81, a quick ratio of 2.97 and a debt-to-equity ratio of 11.97. The stock has a market capitalization of £2.30 billion, a PE ratio of -54.11 and a beta of 0.76.

HUTCHMED Company Profile

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).